Carnegie Investment Counsel’s Sempra SRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.2M Sell
163,919
-3,472
-2% -$323K 0.27% 105
2026
Q1
$14.1M Buy
167,391
+22,408
+15% +$2.05M 0.27% 105
2025
Q4
$12.8M Buy
144,983
+801
+0.6% +$72.9K 0.24% 113
2025
Q3
$13M Buy
144,182
+809
+0.6% +$65.5K 0.24% 116
2025
Q2
$10.9M Sell
143,373
-3,032
-2% -$225K 0.22% 128
2025
Q1
$10.4M Buy
+146,405
New +$11.4M 0.25% 115
2024
Q1
Sell
-3,034
Closed -$227K 510
2023
Q4
$227K Hold
3,034
0.01% 452
2023
Q3
$206K Sell
3,034
-1,940
-39% -$140K 0.01% 467
2023
Q2
$362K Buy
4,974
+516
+12% +$38.8K 0.01% 399
2023
Q1
$337K Sell
4,458
-1,642
-27% -$126K 0.01% 412
2022
Q4
$471K Sell
6,100
-196
-3% -$15.2K 0.02% 366
2022
Q3
$472K Buy
6,296
+2,880
+84% +$233K 0.02% 342
2022
Q2
$257K Buy
3,416
+800
+31% +$64.2K 0.01% 419
2022
Q1
$220K Sell
2,616
-600
-19% -$43.1K 0.01% 456
2021
Q4
$213K Buy
+3,216
New +$204K 0.01% 479

Other funds holding SRE

Carnegie Investment Counsel's SRE Position: Q2 2026 in Review

Carnegie Investment Counsel reduced its Sempra (SRE) stake by 2.1% in Q2 2026, selling an estimated $323K and leaving 163,919 shares worth $13.2M. The position accounts for 0.27% of the portfolio, ranked #105.

Carnegie Investment Counsel first reported a position in SRE in Q4 2021 and has held it in 15 quarters since. The position peaked at $14.1M in Q1 2026. 715 funds tracked by Wall St. Rank hold SRE as of Q2 2026.

  • Carnegie Investment Counsel held 163,919 shares of Sempra worth $13.2M as of Q2 2026.
  • Carnegie Investment Counsel sold 3,472 Sempra shares in Q2 2026, an estimated $323K.
  • Sempra made up 0.27% of Carnegie Investment Counsel's portfolio in Q2 2026, its #105 holding.
  • Carnegie Investment Counsel first reported a position in Sempra in Q4 2021 and has held it in 15 quarters since.
  • Carnegie Investment Counsel's Sempra position peaked at $14.1M in Q1 2026.
  • 715 funds tracked by Wall St. Rank held Sempra as of Q2 2026.

Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.